Heska to Participate in the 41st J.P. Morgan Annual Healthcare Conference

Rhea-AI Summary

Heska Corporation (NASDAQ: HSKA) will participate in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 11, 2023. Kevin Wilson, President & CEO, is scheduled to present at 9:45 a.m. PST. A live audio webcast of his presentation will be available online and archived for 90 days. Additionally, Heska management will engage in one-on-one meetings on the same day. Interested parties can contact J.P. Morgan or Heska's Investor Relations for meeting requests. For more details, visit the J.P. Morgan Healthcare Conference website.

LOVELAND, Colo., Dec. 23, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty solutions, announced that members of Heska's management team will participate in the upcoming 41^st Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

Kevin Wilson, Heska's President & Chief Executive Officer, will present on Wednesday, January 11, 2023 at 9:45 a.m. Pacific Standard Time. A live audio webcast of Mr. Wilson's presentation will be available by visiting Heska J.P. Morgan 2023 Healthcare Conference Webcast. The webcast and presentation will be archived on the Company's website shortly after the event and a replay will be available for 90 days following the conference.

Mr. Wilson and members of Company management will also be participating in one-on-one meetings on January 11^th. To request a meeting, please contact J.P. Morgan at 1x1@jpmorgan.com or Heska Investor Relations at investorrelations@heska.com.

For more information regarding the J.P. Morgan 2023 Healthcare Conference, visit J.P. Morgan Healthcare Conference Website.

About Heska

Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostics, informatics, and specialty healthcare solutions through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production for third-parties, primarily for herd animal health. For more information, please visit www.heska.com.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/heska-to-participate-in-the-41st-jp-morgan-annual-healthcare-conference-301708831.html

SOURCE Heska Corporation

FAQ

When is Heska participating in the J.P. Morgan Healthcare Conference?

Heska will participate in the J.P. Morgan Healthcare Conference on January 11, 2023.

What time will Kevin Wilson present at the conference?

Kevin Wilson will present at 9:45 a.m. Pacific Standard Time on January 11, 2023.

How can I watch Heska's presentation at the J.P. Morgan conference?

You can watch the live audio webcast of Heska's presentation by visiting their official conference page.

Will the presentation be available after the conference?

Yes, the presentation will be archived and available for replay for 90 days after the event.

Who should I contact to schedule a one-on-one meeting with Heska management?

You can contact J.P. Morgan or Heska's Investor Relations to schedule a meeting.